Predicted Trait | |
Reported Trait | Hypertrophic cardiomyopathy |
Mapped Trait(s) | hypertrophic cardiomyopathy (EFO_0000538) |
Score Construction | |
PGS Name | HCM_GRS |
Development Method | |
Name | Genome-wide significant variants |
Parameters | p<5e-8, <5% FDR variants (p<1.56e-6) |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 27 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000146 |
Citation (link to publication) | Harper AR et al. Nat Genet (2021) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
Europe PMC: 33495597 |
[
|
African unspecified | BRRD, HCMR, UKB |
Europe PMC: 33495597 |
[
|
Other admixed ancestry | BRRD, HCMR, UKB |
Europe PMC: 33495597 |
[
|
East Asian | BRRD, HCMR, UKB |
Europe PMC: 33495597 |
[
|
European | BRRD, HCMR, UKB |
Europe PMC: 33495597 |
[
|
South Asian | BRRD, HCMR, UKB |
Europe PMC: 33495597 |
[
|
Not reported | BRRD, HCMR, UKB |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [
|
European, South Asian, African unspecified, East Asian, Other admixed ancestry, NR | BRRD, HCMR | Cases were individuals with hypertrophic cardiomyopathy. | — | — | African Unspecified = 1223, Other admixed ancestry = 268, East Asian = 382, European = 44467, South Asian = 1382, Not reported = 14 | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001765 | PSS000909| Multi-ancestry (including European)| 41,597 individuals |
PGP000146 | Harper AR et al. Nat Genet (2021) |
Reported Trait: Hypertrophic cardiomyopathy | OR: 1.73 [1.63, 1.83] | — | — | Age, gender, PCs(1-10) | — |
PPM001767 | PSS000910| Multi-ancestry (including European)| 20,501 individuals |
PGP000146 | Harper AR et al. Nat Genet (2021) |
Reported Trait: Hypertrophic cardiomyopathy carrying a pathogenic sarcomere mutation | OR: 1.54 [1.39, 1.69] | — | — | Age, gender, PCs(1-10) | — |
PPM001766 | PSS000908| Multi-ancestry (including European)| 21,095 individuals |
PGP000146 | Harper AR et al. Nat Genet (2021) |
Reported Trait: Hypertrophic cardiomyopathy in individuals who do not carry a pathogenic sarcomere mutation | OR: 1.8 [1.67, 1.93] | — | — | Age, gender, PCs(1-10) | — |
PPM018527 | PSS011008| European Ancestry| 184,511 individuals |
PGP000476 | Biddinger KJ et al. JAMA Cardiol (2022) |Ext. |
Reported Trait: Hypertrophic cardiomyopathy | OR: 1.556 [1.361, 1.778] | — | — | — | — |
PPM018528 | PSS011008| European Ancestry| 184,511 individuals |
PGP000476 | Biddinger KJ et al. JAMA Cardiol (2022) |Ext. |
Reported Trait: Hypertrophic cardiomyopathy in noncarriers of an HCM-ACMG rare variant | OR: 1.585 [1.375, 1.828] | — | — | — | — |
PPM018529 | PSS011007| European Ancestry| 30,716 individuals |
PGP000476 | Biddinger KJ et al. JAMA Cardiol (2022) |Ext. |
Reported Trait: Hypertrophic cardiomyopathy | OR: 1.35 [1.21, 1.51] | — | — | — | — |
PPM018530 | PSS011008| European Ancestry| 184,511 individuals |
PGP000476 | Biddinger KJ et al. JAMA Cardiol (2022) |Ext. |
Reported Trait: Hypertrophic cardiomyopathy | HR: 1.795 [1.521, 2.117] | AUROC: 0.725 [0.678, 0.771] | — | Age, sex, genotyping array, and PCs 1-5 | — |
PPM018531 | PSS011008| European Ancestry| 184,511 individuals |
PGP000476 | Biddinger KJ et al. JAMA Cardiol (2022) |Ext. |
Reported Trait: Hypertrophic cardiomyopathy | — | AUROC: 0.821 [0.772, 0.871] | — | Clinical risk factors (obesity, HTN, AF, CAD), HCM-ACMG rare variant carrier status, age, sex, genotyping array, and PCs 1-5 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | African unspecified | — | GEL, RBH-CRB | — |
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Other admixed ancestry | Ad Mixed American | GEL, RBH-CRB | — |
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | East Asian | — | GEL, RBH-CRB | — |
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | European | — | GEL, RBH-CRB | — |
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | South Asian | — | GEL, RBH-CRB | — |
PSS000908 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Not reported | — | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | African unspecified | — | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Other admixed ancestry | Ad Mixed American | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | East Asian | — | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic cardiomyopathy. In the individuals recruited from the Netherlands, this was identified using current diagnostic criteria(eft ventricular wall thickness ≥15mm or ≥13mm in presence of family history) | — | [
|
— | European | — | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic Cardiomyopathy. | — | [
|
— | South Asian | — | GEL, RBH-CRB | — |
PSS000909 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Not reported | — | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | African unspecified | — | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Other admixed ancestry | Ad Mixed American | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | East Asian | — | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | European | — | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | South Asian | — | GEL, RBH-CRB | — |
PSS000910 | Cases were individuals with hypertrophic cardiomyopathy. | — | [
|
— | Not reported | — | GEL, RBH-CRB | — |
PSS011007 | HCM was defined as having an ICD-10 code of I42.1 or I42.2, in addition to a mention of “hypertrophic cardiomyopathy,” “hypertrophic obstructive cardiomyopathy,” “HCM,” or “HOCM” | — | 30,716 individuals, 45.37 % Male samples |
Mean = 57.23 years | European | — | MGBB | — |
PSS011008 | HCM cases were identified by the presence of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10), billing code I42.1 (hypertrophic obstructive cardiomyopathy) or I42.2 (other hypertrophic cardiomyopathy) | — | 184,511 individuals, 45.35 % Male samples |
Mean = 56.51 years | European | — | UKB | — |